TRAF3IP2 promotes the progression of NONO-TFE3 tRCC by activating the NOTCH signaling pathway. This evidence concerns the gene TRAF3IP2 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.